PW Medtech Group Limited, an investment holding company, operates as a medical device company in China, India, the Americas, Africa, the rest of Asia, and internationally. It operates in three segments: Infusion Set Business; Blood Purification Business; and Regenerative Medical Biomaterials Business. The company offers advanced infusion sets, such as non-PVC-based infusion sets, precision filter infusion sets, light-resistant infusion sets, intravenous cannula products, and insulin needles and pens; hemodialysis and blood purification medical devices; and high-flux hemodialyzers, low-flux hemodialyzers, hemodiafilters, hemoperfutors, and dialysis machines. It also provides animal-derived regenerative medical biomaterials and human tissue repair alternative products. The company was formerly known as Pyholding Limited and changed its name to PW Medtech Group Limited in June 2013. PW Medtech Group Limited was founded in 1997 and is headquartered in Beijing, the People's Republic of China.
Research context
PW Medtech Group Limited appears in PyInvesting’s Hong Kong Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- HKD
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
PW Medtech Group Limited is currently in a long term uptrend where the price is trading 8.4% above its 200 day moving average.
From a valuation standpoint, the stock is 97.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.9.
PW Medtech Group Limited's total revenue sank by 46.5% to $102M since the same quarter in the previous year.
Its net income has increased by 538.3% to $141M since the same quarter in the previous year.
Finally, its free cash flow grew by 323.6% to $18M since the same quarter in the previous year.
Based on the above factors, PW Medtech Group Limited gets an overall score of 4/5.